| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 68.47B | 83.08B | 67.72B | 88.47B | 79.06B | 72.58B |
| Gross Profit | 10.14B | 12.70B | 9.01B | 10.60B | 9.30B | 8.58B |
| EBITDA | 5.59B | 6.77B | 4.68B | 6.09B | 5.21B | 4.35B |
| Net Income | 2.96B | 4.29B | 2.90B | 2.96B | 2.12B | 1.23B |
Balance Sheet | ||||||
| Total Assets | 95.27B | 119.33B | 108.08B | 107.47B | 108.51B | 102.98B |
| Cash, Cash Equivalents and Short-Term Investments | 8.43B | 9.82B | 7.77B | 12.30B | 13.26B | 10.09B |
| Total Debt | 9.30B | 18.13B | 19.62B | 6.95B | 9.19B | 8.65B |
| Total Liabilities | 26.49B | 46.87B | 39.65B | 38.93B | 42.58B | 38.51B |
| Stockholders Equity | 68.77B | 72.45B | 68.43B | 68.55B | 66.26B | 64.63B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.82B | -15.99B | 7.57B | 4.19B | -12.02B |
| Operating Cash Flow | 0.00 | 4.71B | -15.23B | 8.50B | 8.14B | -5.73B |
| Investing Cash Flow | 0.00 | 931.00M | -90.00M | -5.13B | -3.12B | -385.00M |
| Financing Cash Flow | 0.00 | -3.67B | 10.65B | -4.45B | -656.00M | 5.78B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥266.74B | 9.89 | 7.43% | 2.78% | 2.69% | -6.90% | |
78 Outperform | ¥1.42T | 17.13 | 14.94% | 2.00% | 10.44% | 50.36% | |
78 Outperform | ¥672.68B | 11.33 | ― | 2.15% | 0.46% | 38.67% | |
77 Outperform | ¥47.11B | 6.36 | 7.09% | 3.06% | 9.75% | 22.98% | |
77 Outperform | ¥98.29B | 6.30 | ― | 4.38% | -6.07% | 44.83% | |
73 Outperform | ¥72.02B | 13.47 | ― | 2.95% | 22.68% | 48.79% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |